ORLANDO, Fla. — Nine years since the Pulse nightclub terror attack, work now begins Monday to remove artifacts from inside the former nightclub — the first of ...

In this week’s edition of InnovationRx, we look at Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real world, using “boring” AI in clinics and more.

The companies said on Tuesday that Danaher will pay $180 per share to buy Masimo. The offer represents a premium of 38.3% to Masimo's last close.

Life sciences firm Danaher is closing in on a nearly $10 billion deal to acquire pulse oximeter maker Masimo , the Financial Times reported on Monday, citing sources.

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a new strategic partnership with PromptCare, a leading ...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or ...

ORLANDO, Fla. – The city of Orlando is moving forward with plans to create a permanent memorial at the Pulse nightclub site with removal of the existing building expected to begin in mid-March, ...

A major UK study shows that commonly used home pulse oximeters can overestimate oxygen levels in people with darker skin, increasing the risk of undetected hypoxemia and raising urgent questions about ...

In the EXAKT study from the U.K., the home-use pulse oximeters assessed all gave higher oxygen saturation (SpO2) readings for patients with darker skin tones than for patients with lighter skin tones.

Fingertip monitors known as pulse oximeters that can be used at home to detect low blood oxygen levels (hypoxaemia) give higher readings for patients with darker than lighter skin tones, finds the ...

DALLAS — The Dallas PULSE has secured a new streaming home for its inaugural season. The franchise announced a partnership with Victory+ that will make the free platform the exclusive streaming ...

The long-awaited study, which was commissioned by the FDA in hopes of reducing racial bias, found results that contradict past research findings, leaving clinicians confused. Also: FDA Commissioner ...